Algeria, Germany, Turkey ink 29.9-mln-USD deal to produce hypertension, diabetes drugs

Source: Xinhua| 2019-01-15 04:26:31|Editor: yan
Video PlayerClose

ALGIERS, Jan. 14 (Xinhua) -- The Algerian-Turkish pharmaceuticals company Abdi Ibrahim Remede Pharma (AIRP) on Monday signed a 20-million-euro (29.9-million-U.S. dollar) agreement with its German opposite number Boehringer Ingelheim to produce drugs treating hypertension and diabetes.

According to the agreement, the medications Micardi.plus (against high blood pressure) and Jardiance (against Type 2 diabetes) will be produced locally.

The two drugs will be made by AIRP production unit in the new city of Sidi Abdullah in Algiers' western district.

Bachir Batel, the director general of Boehringer Ingelheim, said the production of drugs to treat tye 2 diabetes will start in the second quarter of 2019, to be available in the second half of 2023.

He added that the production of hypertension drugs will start by April 2021 and will be available on the Algerian market in the second quarter of 2021.

For his part, Mohamed Lamine Bousteila, AIRP's representative, said investing 20 million euro in this project comprises equipment, technology transfer and training.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011105521377438531
国产无码在线观看免费在线,37pao国产成视频,日韩一区二区视频在线,国产国产人免费人成免费视频麻豆
亚洲欧美日韩精品一区二区 | 亚洲人成网站在线观看香蕉 | 亚洲日本视频在线观看 | 亚洲日韩一区二区午夜福利蜜桃 | 伊人成亚洲综合人网香 | 亚洲人成在线俺来了 |